Drugs
Optimizing Antimicrobial Prescribing Through Diagn
Optimizing Antimicrobial Prescribing Through Diagnostic Improvement

Utilizing appropriate diagnostic tests with rapid turnaround times helps reduce antibiotic overuse, offering a targeted approach to antimicrobial prescribing.

August 2023

Predictors of Drug-Free Type 2 Diabetes Remission
Predictors of Drug-Free Type 2 Diabetes Remission Explored

Insights from an 8-year evaluation of a low-carbohydrate diet with weight loss shed light on predictors of drug-free type 2 diabetes remission, offering valuable perspectives for clinical management.

August 2023

Effect of High-Intensity Training on Coronary Plaq
Effect of High-Intensity Training on Coronary Plaques

HIIT is associated with a regression of atheroma volume in patients with stable coronary artery disease

August 2023

Influence of Age on Myocardial Infarction Diagnosi
Influence of Age on Myocardial Infarction Diagnosis

The specificity and positive predictive value of high-sensitivity cardiac troponin decrease with age

August 2023

FDA Approves First Drug to Delay Onset of Type 1 D
FDA Approves First Drug to Delay Onset of Type 1 Diabetes

The FDA approves a groundbreaking drug that offers patients months or years free from the burden of type 1 diabetes.

July 2023

Antibiotic Administration Reduces Infection Risk i
Antibiotic Administration Reduces Infection Risk in Colorectal Surgery

Adding oral antibiotics to intravenous antibiotics significantly reduces the incidence of surgical incision site infection in patients undergoing elective colorectal surgery.

July 2023

COVID-19 Raises Risk of Secondary Infections
COVID-19 Raises Risk of Secondary Infections

Gut microbiome dysbiosis in COVID-19 patients treated with antibiotics is associated with microbial translocation and bacteremia, increasing the risk of dangerous secondary infections.

July 2023

Eradication of Helicobacter pylori in Peptic Ulcer
Eradication of Helicobacter pylori in Peptic Ulcer Bleeding Prevention

Eradicating Helicobacter pylori protects against peptic ulcer bleeding associated with aspirin use, but the long-term efficacy of this approach may be limited, highlighting the need for continued research into preventive strategies.

June 2023

Linaclotide’s Potential in Bladder-Colon Cross-Sensitization

Linaclotide’s ability to modulate cross-talk between the bladder and colon determines its therapeutic potential in patients with painful bladder syndrome and irritable bowel syndrome, offering a promising treatment avenue.

June 2023

Long-Term Impact of Helicobacter pylori Eradicatio
Long-Term Impact of Helicobacter pylori Eradication on Peptic Ulcer Bleeding

Eradicating Helicobacter pylori protects against peptic ulcer bleeding associated with aspirin use, but the long-term sustainability of this protective effect remains uncertain.

June 2023

Allergies Artificial Intelligence Cancer Cardiovascular Child care Covid Diabetes Drugs Exercising Food & Health Hypertension Microbiology Neurology Obstetrics Ophtalmology Oral health Respiratory Skin care Sleep Smoking Surgery Vaccines Women's health
Top reads...
Reevaluating Sunlight Exposure New Study Unveils Effective TB Prevention Strategy Smoking, Alcohol Consumption, and Risk of Incident Diverticulitis Rotator cuff surgery Differences in the Top 20 Causes of Illness Between Men and Women